It has been proposed that the increase in renal blood flow (RBF) produced by bradykinin (BK) is mediated or amplified by the intrarenal generation of prostaglandins. The present investigation was designed to explore these relationships further. In anesthetized dogs, the renal arterial infusion of BK (100 ng/kg per min), prior to the intravenous administration of indomethacin, produced a 93 ± 14% increase in RBF and an increase in the renal venous concentration of a prostaglandin E-like substance ("PGE") from 51 ± 23 to 235 ± 73 pg/ml as determined by bioassay. Following indomethacin (5 mg/kg), the same dose of BK produced a 151 ± 18% increase in RBF (P < 0.001 compared to the preindomethacin increase) and the concentration of "PGE" remained largely below the threshold of sensitivity of the bioassay system. In three experiments, a highly sensitive and specific radioimmunoassay technique was used to obtain better quantitative estimates of concentrations of E2-like ("PGE2") and F2»-like ("PGF2,,") substances so that determinations of renal efflux could be made. Thus, prior to indomethacin, BK administration increased RBF by 142 ± 39 ml/min and was associated with a 26-fold increase in renal efflux of "PGE2" and a 12-fold increase in "PGF 2o ." After indomethacin, the effluxes of both "PGE2" and "PGF2,," decreased to negligible levels and were not influenced by BK infusion, although RBF increased by 225 ± 75 ml/min. These results are not compatible with the hypothesis that intrarenal prostaglandins mediate or amplify the renal vasodilator response to BK.
Inhibition of Prostaglandin Synthesis by Indomethacin Augments the Renal Vasodilator
SUMMARY It has been proposed that the increase in renal blood flow (RBF) produced by bradykinin (BK) is mediated or amplified by the intrarenal generation of prostaglandins. The present investigation was designed to explore these relationships further. In anesthetized dogs, the renal arterial infusion of BK (100 ng/kg per min), prior to the intravenous administration of indomethacin, produced a 93 ± 14% increase in RBF and an increase in the renal venous concentration of a prostaglandin E-like substance ("PGE") from 51 ± 23 to 235 ± 73 pg/ml as determined by bioassay. Following indomethacin (5 mg/kg), the same dose of BK produced a 151 ± 18% increase in RBF (P < 0.001 compared to the preindomethacin increase) and the concentration of "PGE" remained largely below the threshold of sensitivity of the bioassay system. In three experiments, a highly sensitive and specific radioimmunoassay technique was used to obtain better quantitative estimates of concentrations of E2-like ("PGE2") and F2»-like ("PGF2,,") substances so that determinations of renal efflux could be made. Thus, prior to indomethacin, BK administration increased RBF by 142 ± 39 ml/min and was associated with a 26-fold increase in renal efflux of "PGE2" and a 12-fold increase in "PGF 2o ." After indomethacin, the effluxes of both "PGE2" and "PGF2,," decreased to negligible levels and were not influenced by BK infusion, although RBF increased by 225 ± 75 ml/min. These results are not compatible with the hypothesis that intrarenal prostaglandins mediate or amplify the renal vasodilator response to BK.
A PROSTAGLANDIN E-like substance ("PGE") of renal origin has been implicated as a major participant in the local control of blood flow to the kidney. 1 This fundamental relationship between renal blood flow (RBF) and rate of prostaglandin synthesis within the kidney was suggested by the findings that augmentation of renal prostaglandin synthesis produced by either mechanical reduction of RBF 2 or administration of pressor agents 3 " 5 was associated with attenuation of renal vasoconstriction, whereas inhibition of prostaglandin synthesis produced by either of two chemically dissimilar anti-inflammatory acids, indomethacin or meclofenamate, was associated with a reduction of RBF. 6 These alterations in RBF which occur consequent to changes in rates of renal prostaglandin synthesis do not appear to be homogeneously distributed throughout the kidney; viz, influences which tend to suppress synthesis of prostaglandins are associated with redistribution of intrarenal flow to outer cortical nephrons 7 whereas enhanced rates of renal prostaglandin synthesis favor redistribution of flow to juxtamedullary areas. 8 ' 9 The renal vasodilator nonapeptide, bradykinin (BK), which augments inner cortical flow, 10 in-creases the concentration of "PGE" in renal venous blood when infused into the renal artery of anesthetized dogs. 11 ' 12 Renal prostaglandins were, therefore, suggested as possible mediators of the renal vasodilator effects of this kinin. 11 ' 12 This proposal was strengthened by the observation that, in the isolated perfused canine kidney, the renal vasodilator action of BK was attenuated following administration of indomethacin. 13 Recently, however, the relationship between generation of prostaglandins and renal hemodynamic events produced by BK has been confounded by several reports. In the rabbit kidney perfused at constant flow, neither BK nor kininogen affected renal perfusion pressure, whereas "PGE" concentration was increased at least 6-fold. 14 Moreover, in the in situ perfused feline kidney, the renal vasodilator response to BK was reported to be enhanced following the administration of indomethacin. 15 The present investigation was designed to define more clearly the relationship between BK and "PGE" in producing alterations of RBF in the anesthetized dog. If prostaglandins do mediate or amplify the vasodilator response to BK, then blockade of prostaglandin synthesis should be associated with the elimination, or at least an attenuation, of the renal vasodilator response to BK. In the experiments to be described, we used biochemical and pharmacological techniques to identify and quantify "PGE" in renal venous blood and in renal medullary slices. In addition, a highly sensitive and specific radioimmunoassay technique was used to obtain better quantitative estimates of "PGE" con- VOL. 43, No. 3, SEPTEMBER 1978 centration for the determination of renal efflux of "PGE."
Methods
Male mongrel dogs (24-32 kg), fasted overnight but allowed free access to water, were anesthetized with either sodium pentobarbital (30 mg/kg, iv) or morphine (2 mg/kg, sc) and chloralose (100 mg/kg, iv). An intravenous infusion of 0.9% saline was given throughout the experiment at 4-6 ml/min. Ventilation was maintained by means of a cuffed endotracheal tube attached to a Harvard respirator (model 618) open to air. Tidal volume and respiratory rate were adjusted so that mean (± SE) arterial pH was 7.39 ± 0.01 and Po 2 and Pco 2 were 95 ± 3 and 29 ± 2 mm Hg, respectively. Mean aortic blood pressure was measured with a Statham pressure transducer (model P23Db) attached to a catheter introduced into the aorta via the right femoral artery. The abdomen was opened by means of a transabdominal incision and the right renal artery and vein were isolated. A Micron electromagnetic flowmeter (model RC1000), with nonocclusive zero feature was used for continuous measurement of RBF. The renal vein was catheterized via the left femoral vein to obtain samples for prostaglandin determination. When multiple renal arteries were present on the right, the contralateral vessels were used. Renal arterial infusions (Harvard infusion pump, model 941) were made using a 23-gauge needle inserted directly into the renal artery. Patency of the renal arterial needle was maintained by the constant infusion of 0.9% saline at 0.2 ml/min. A stock solution (1 mg/ml) of BK, stored at -20°C, was prepared by dissolving bradykinin triacetate dihydrate (Calbiochem) in a 0.9% NaCl solution. On the day of the experiment, the concentration of BK was adjusted with 0.9% saline so that the infusion rate into the renal artery did not exceed 0.2 ml/min. Each BK infusion into the renal artery was of 12 minutes duration.
Renal venous samples for estimates of "PGE" concentration were obtained immediately before and during the intrarenal arterial infusion of BK (100 ng/kg per min) both prior to and after the intravenous administration of indomethacin (5 mg/kg). Blood collection during BK administration was started at the time that RBF began to increase and was completed within 2 minutes. Indomethacin was dissolved in 15 ml 95% ethanol and the volume adjusted to 100 ml with Krebs' solution just prior to intravenous administration. A 6% solution of dextran (average molecular weight: 70,000) was infused intravenously at the rate at which renal venous blood was removed.
"PGE" was identified and quantified using modifications of extraction, chromatographic, and bioassay procedures previously described. 3 Blood samples (100 ml) were collected in plastic syringes and placed immediately into 300 ml of cold 95% ethanol containing 0.2 juCi PGE 2 [ a H] (specific activity: 117 Ci/mM). The PGE 2 [ 3 H] permitted estimates to be made of the losses incurred on extraction and purification. The ethanolic mixtures were stored at -20°C for 1 hour prior to centrifugation in the cold (0°C) at 738 g for 10 minutes. The supernatant fluid was removed and extracted as previously described. 3 For further purification, the extract was spotted along the origin line of a 20 x 20 cm, 0.5 mm thick silica gel plate (Silica Gel 60 F-254, Brinkman Co.). The plates were developed for 15 cm in chloroform-methanol-acetic acid (18:2:1 by volume). Identical silica gel plates were spotted with authentic prostaglandins and developed in the same manner as the sample plates. PGE zones on these standard plates were identified by spraying the plates with an ethanolic solution of phosphomolybdic acid and heating them for 5 minutes at 120° C. The zone of the aliquot plate corresponding to the PGE zone of the standard plate, as well as zones on either side of the PGE zone, were scraped, eluted with three samples (2 ml) of chloroformmethanol (4:1 by volume), and the eluates dried under nitrogen at 40°C. The residue from each dried eluate was dissolved in 0.5 ml of a 0.9% NaCl solution for bioassay. An aliquot (10 /il) of each reconstituted sample was removed and counted (Beckman LS100 scintillation counter) to determine recovery of PGE 2 [ 3 H] after extraction and purification. The mean recovery of PGE 2 [ 3 H] in 65 samples under these experimental conditions was 50 ± 1%. In addition, the PGE 2 [ 3 H] served as an internal standard so that migration of PGE to chromatographic zones other than those presumed to be PGE zones by comparison with standard plates, could be identified readily. Concentrations of "PGE" expressed in this paper were not corrected for losses incurred on extraction and purification. Reconstituted eluates from both PGE and flanking zones were bioassayed using tissues (rat stomach strip and rat colon) superfused in series with Krebs' solution maintained at 37°C and gassed with 95% oxygen and 5% carbon dioxide. Concentrations of "PGE" expressed as PGE 2 -equivalents in pg/ml were determined by bracket assay with authentic PGE 2 standards. 3 The threshold of detectability of this method was 25 pg/ml. Each eluate was assayed in triplicate and the value expressed as the mean of the three determinations.
In several experiments, the concentrations of PGE 2 -like ("PGE 2 ") and PGF^-like ("PGF,,,") substances were determined using a modification of the radioimmunoassay procedure described by Dray et al. 16 A 35-ml blood sample was collected in a chilled 50-ml plastic syringe containing EDTA. The blood was placed on ice and centrifuged within 30 minutes. The plasma was removed and stored frozen at -20°C. A 10-ml sample was acidified to pH 3 with 1 M citric acid. The acidified mixture was extracted twice with 30 ml of cyclohexane-ethyl acetate (1:1 
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by volume). The volume of the organic phase was reduced by evaporation in vacuo. PGA and PGB were separated from PGE, and PGE from PGF on silicic acid columns by using solvent mixtures (benzene-ethyl acetate-methanol) of increasing polarity. Each prostaglandin fraction was evaporated to dryness under nitrogen at 40°C. The radioimmunoassay was carried out in glass tubes (10 X 75 mm) at room temperature, using 0.1 ml of the PGE fraction brought up in 0.8 ml with buffer (phosphatebuffered saline at pH 7.4, 0.1% sodium azide, and 0.1% gelatin). Prostaglandin E 2 -antiserum (Institut Pasteur) was incubated with a fixed quantity of PGE 2 [ 3 H] (specific activity: 117 Ci/mmol) and the unknown sample. A dextran-charcoal solution was added after incubation to separate bound from free PGE 2 . A standard curve was generated along with each set of unknowns. As can be seen from the mean standard curve in Figure 1 , this is a highly sensitive method for the determination of "PGE." In addition, the high degree of specificity of this antibody for PGE 2 is shown by the cross-reactivity curves which are generated when this antibody is reacted with other prostaglandins (Fig. 1 ). Similar procedures were carried out for the determination of "PGF 2a ."
To verify the blockade of prostaglandin synthesis by indomethacin, several combined in vivo and in vitro experiments were performed. In these experiments (n = 3), one kidney was removed prior to the first infusion of BK (pre-indomethacin) and the other kidney was removed after the second infusion of BK (post-indomethacin). Two grams of medullary slices (0.5 mm thick) were added to an incubation mixture consisting of Krebs' bicarbonate buffer (20 ml), arachidonic acid[l-14 C] (0.1 jiCi), and glutathione (2 mM). In one of these experiments, 2 mg of unlabeled arachidonic acid were added to the incubation mixture. The mixture was gassed with 95% oxygen and 5% carbon dioxide. After incubation for 1 hour at 37°C, the reaction was stopped by the addition of 60 ml of cold 95% ethanol. Following filtration and reduction of the pH to 2.0, the filtrate was extracted with chloroform-methanol (2:1 by volume). The organic phase was evaporated in vacuo. The residue from each sample was redissolved in chloroform-methanol (4:1 by volume) and spotted along the origin of a 0.25 mm thick, 5 X 20 cm Brinkman silica gel plate. Identical silica gel plates were spotted with standard solutions of labeled PGE 2 , PGA 2 , PGF 2a , and arachidonic acid (New England Nuclear). All plates were developed in chloroform-methanol-acetic acid (18:2:1 by volume) for 15 cm, and were scanned with a Packard radiochromatogram scanner equipped with a disc integrator to localize and quantify radioactivity. Following identification of the zones of PGE activity, these zones were scraped, eluted with chloroform-methanol (4:1 by volume), and bioassayed as described above.
For all statistical analyses, each dog served as its own control. Analyses were performed using the Student's t-test for paired data.
Results
The infusion of BK (100 ng/kg per min) into the renal artery prior to the administration of indomethacin was associated with increases in RBF and the renal venous concentration of "PGE" as determined by bioassay (Fig. 2) . In 13 dogs, RBF increased from a mean (± SE) control value of 184 ± 16 to 347 ± 27 ml/min (Table 1) . Simultaneously, the renal venous concentration of "PGE" increased from 51 ± 23 to 235 ± 73 pg/ml (Table 1) . Mean aortic blood pressure was unchanged by the administration of BK. Following cessation of BK infusion and the establishment of a new steady baseline RBF at 170 ± 15 ml/min, indomethacin (5 mg/kg) was administered intravenously. Thirty minutes after the administration of indomethacin, RBF had decreased to 156 ± 13 ml/min (P < 0.02) and the concentration of "PGE" had decreased from 19 ± 7 pg/ml to 9 ± 6 pg/ml. Upon reinfusion of BK, the RBF response was undiminished (Fig. 2) , increasing from 156 ± 13 ml/min to 376 ± 27 ml/min (Table  1) , whereas, the concentration of "PGE" in renal venous blood did not increase in response to BK after pretreatment with indomethacin. The increase VOL. 43, No. 3, SEPTEMBER 1978 "PGE" (pg/ml) in RBF following indomethacin administration was significantly greater (P < 0.001) than that observed prior to indomethacin administration. This augmented renal vasodilator response to BK following indomethacin administration did not appear to be a time-related event. Thus, in eight additional experiments in which blood samples were not obtained and dextran was not administered, the renal vasodilator response to an infusion of BK (100 ng/kg per min) into the renal artery was potentiated following indomethacin administration (four dogs); whereas, in the four dogs treated with indomethacin vehicle (15 ml 95% ethanol, 85 ml Krebs' solution) alone, no such potentiation was observed (Fig. 3) . In Figure 3 , the difference in renal vasodilator response to BK prior to and after the administration of indomethacin or indomethacin vehicle is expressed as a percent of the initial response to BK.
Estimates of efflux of "PGE" (RBF X renal venous concentration of "PGE") could not be made in the experiments described above since the concentrations of "PGE" in samples obtained after the administration of indomethacin were, in large part, less than the threshold of detectability for the bioassay system (25 pg/ml) ( Table 1 ). To circumvent this problem, a highly specific and sensitive radioimmunoassay technique for PGE2 (threshold: 0.48 ± 0.01 pg/ml) ( Fig. 1 ) and PGF 2 Q (threshold: 0.41 ± 0.01 pg/ml) was used in three experiments. Thus, prior to the administration of indomethacin, the infusion of BK (100 ng/kg per min) into the renal artery produced an increase of 142 ± 39 ml/min in RBF. Simultaneously, the renal venous concentration of "PGE 2 " increased by 918 ± 51 pg/ml from a control of 76 ± 50 pg/ml. Similarly, the concentration of "PGF 2a " increased from 30 ± 20 pg/ml to 220 ± 27 pg/ml. Following indomethacin administration, the renal venous concentrations of "PGE 2 " and "PGF^" were reduced to 14 ± 8 and 7 ± 1 pg/ml, respectively. Reinfusion of BK into the renal artery (100 ng/kg per min) increased RBF by 225 ± 75 ml/min, whereas neither "PGE 2 " nor "PGF 2a " concentrations in renal venous blood were changed. When expressed in terms of prostaglandin efflux, the initial response to BK infusion was associated with a 26-fold increase of "PGE 2 " and a 12fold increase in "PGF 2a ." In contrast, after indomethacin administration, there were negligible changes in efflux of both "PGE 2 " and "PGF^" in response to BK infusion. In vitro verification of blockade of prostaglandin synthesis by indomethacin was obtained by incubation of renal medullary slices with arachidonic acid (Fig. 4) . Medullary slices of the kidney removed prior to indomethacin administration incorporated 4.57% of the radioactivity into substances which exhibited chromatographic properties indistinguishable from prostaglandins of the E and F series. In contrast, medullary slices of the kidney removed after indomethacin administration exhibited markedly reduced incorporation of radiolabel into prostaglandin E and F zones (Fig. 4) . When the PGE zone of the chromatographic plate was removed, eluted, and bioassayed, the amount of "PGE" generated by the kidney removed after indomethacin administration was negligible when compared to the amount of "PGE" generated by the kidney removed prior to indomethacin administration. Furthermore, the addition of 2 mg of unlabeled arachidonic acid was associated with the production of 182 ng/g of "PGE" by a kidney removed prior to indomethacin administration and 6 ng/g of "PGE" by a kidney removed after indomethacin.
Discussion
The capacity of BK to alter rates of prostaglandin synthesis has been documented amply, not only in the intact kidney, 11 ' 12 ' 14 but also in blood vessels, 17 ' 18 in tissue culture, 19 ' 20 and in the heart. 21 The relationship between the increased rates of prostaglandin synthesis on the one hand, and vascular events on the other, which occur consequent to BK administration, remains, however, unclear. Thus, following application of agents which are known to inhibit prostaglandin synthesis, it has been reported that, in response to BK, arteriolar dilator responses are reduced, 22 venoconstrictor responses enhanced, 23 decreases in coronary resistance abolished, 21 and renal vasodilator responses either attenuated 13 or augmented. 15 In only one of these studies, however, was any attempt made actually to measure prostaglandins. 21 Prostaglandins were implicated as participants in the hemodynamic alterations by virtue VOL. 43, No. 3, SEPTEMBER 1978 lOOr- FIGURE 4 Radiochromatograms of substances produced by the incubation of arachidonic acidfl-u CJ with slices of renal medulla obtained from a dog before (a) and after (b) administration of indomethacin. Comparison of the peaks of radioactivity with a standard plate (lower) reveals that, prior to treatment with indomethacin, radioactivity was incorporated into substances which exhibited the chromatographic properties of prostaglandins of the E and F series, whereas, after indomethacin, no such incorporation is observed. M denotes a radioactive marker spotted 1.5 cm from the end of the 20-cm plate.
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of the fact that changes were noted after administration of agents known to inhibit prostaglandin synthesis. This may account, at least in part, for the apparent discrepancies; for, prior to the assignment of a role for prostaglandins through use of the "subtraction method," 24 a necessary first step must be the demonstration that under the particular experimental conditions the stimulus does indeed increase rates of prostaglandin synthesis. Second, after administration of the prostaglandin synthe-
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tase inhibitor, the degree of suppression of prostaglandin synthesis must be defined. The latter consideration is of importance in view of the highly variable amounts of prostaglandin synthetase inhibitor required to block prostaglandin synthesis under some experimental conditions 25 and the potential lack of specificity of these agents. 26 The results reported here do not support the proposal that the renal vasodilator effects of BK are either mediated or amplified by the intrarenal generation of pros-taglandins. On the contrary, indomethacin appears to enhance the renal vasodilator response to BK. Thus, prior to the intravenous administration of indomethacin, BK produced a 93 ± 14% increase in RBF and a 4-fold increase in the renal venous concentration of "PGE" as determined by bioassay (Table 1) . Thirty minutes after the administration of the prostaglandin synthetase inhibitor, reinfusion of BK was associated with a 151 ± 18% increase in RBF, which was a significantly greater increase in blood flow (P < 0.001) than had been seen prior to indomethacin administration. Concomitantly, the concentration of "PGE" in renal venous blood remained largely below the threshold of detectability of the bioassay system (Table 1) . These hemodynamic results are in agreement with those reported by Chapnick et al. 15 for the in situ perfused cat kidney and in disagreement with the finding of McGiff et al. 13 who reported an attenuated blood flow response to BK in the isolated perfused canine kidney after the administration of indomethacin. Since prostaglandin measurements were not performed in this latter study, relationships that might exist between RBF and rates of prostaglandin synthesis as altered by BK are difficult to interpret and may account for the differences in results. Moreover, results of studies in the isolated perfused kidney might not be expected to conform to those performed in the intact animal, since, among other things, the prostaglandin concentration in the perfusing blood increases with time and, although treatment with indomethacin reduces the prostaglandin concentration, it still remains at a level considerably higher than that found in arterial blood and comparable to values reported in renal venous blood. 1 In the present experiments, considerable effort was made to define the state of prostaglandin synthesis after treatment with indomethacin. Since efflux is defined by the product of venous concentration and blood flow, only crude estimates of "PGE" efflux after the administration of indomethacin could be made when the results obtained with bioassay were used. Thus, if one were to assume that the concentration of "PGE" in renal venous blood when below the threshold of detectability of the bioassay system was the maximum possible value, namely 25 pg/ml, then the renal efflux of "PGE" following blockade of prostaglandin synthesis and in response to the infusion of BK into the renal artery would be 10.2 ± 1.1 ng/min or less than one-seventh that seen prior to blockade of prostaglandin synthesis. This marked decrease in renal efflux of "PGE" occurred despite the fact that the increase in RBF in response to BK after the blockade of prostaglandin synthesis was greater in terms of both percentage and absolute increase than had been observed prior to blockade of prostaglandin synthesis (Table 1) .
In three experiments, more accurate assessments of both "PGE 2 " and "PGF 2o " efflux could be made because we used a highly sensitive and specific radioimmunoassay technique (Fig. 1) . Thus, the increase in RBF in response to the infusion of BK into the renal artery was associated with 25-and 15-fold increases in the renal efflux of "PGE 2 " and "PGF2 O ," respectively, prior to the administration of indomethacin. The efflux of both of these substances after blockade of prostaglandin synthesis was reduced virtually to zero and unaffected by the administration of BK. Biochemical evidence also was obtained to verify the inhibition of prostaglandin synthetase. Slices of kidneys that had been removed prior to the intravenous administration of indomethacin incorporated radiolabeled arachidonic acid into products which exhibited the chromatographic characteristics of prostaglandins of the E and F series ( Fig. 4 ). When exogenous substrate was added to one of the incubation mixtures, the amount of "PGE" produced, as determined by bioassay, was augmented considerably. In contrast, slices of kidneys removed after indomethacin administration incorporated virtually none of the radioactivity into "PGE" or "PGF." Similarly, addition of arachidonic acid produced virtually no increase in the synthesis of "PGE."
Among the effects of BK on the kidney, it appears that at least two are independent of each other, namely, the capacity to promote prostaglandin synthesis within the kidney and the effect on total RBF. We have not addressed the question of consequences of increased prostaglandin synthesis within the kidney resulting from BK administration, although these may be resolved in terms of the effects of prostaglandins on distribution of RBF within the kidney and/or on the excretion of salt and water, as recently suggested. 13 The renal venous concentrations of "PGE" in the present experiments were considerably less than those reported previously, both prior to and during the administration of BK into the renal artery. 12 Moreover, the decrease in renal blood flow produced by the intravenous administration of indomethacin was modest (6%) compared to that previously reported. 6 Since similar procedures were used for the extraction, purification and bioassay of "PGE" in renal venous blood, these differences are difficult to explain. In response to BK infusion, the hemodynamic responses were the same whether sodium pentobarbital or morphine-chloralose anesthesia was used. Similarly, the renal venous concentrations of "PGE" prior to and during BK administration were not affected by anesthetic agent. In the present experiments, tissues supervised via an extracorporeal circuit were not used. Whether or not this contributed to the lower values for "PGE," as suggested by Satoh and Zimmerman, 27 cannot be assessed from our results. The smaller decrement in RBF in the present experiments following the administration of indomethacin is, however, consistent with the smaller control values of "PGE" in renal venous blood.
The augmentation of the renal vasodilator response to BK following indomethacin administration was not related to changes in vascular reactivity which might have occurred with the passage of time. Thus, in experiments in which BK was given prior to and after the administration of indomethacin vehicle, no potentiation of the renal vasodilator response was observed (Fig. 3) . Although not explored further in the present study, the augmented renal vascular response to BK following indomethacin administration might be resolved in terms of an interaction between the anti-inflammatory agent and formation of endogenous kinins. Thus, if endogenous concentrations of kinins were reduced by indomethacin because of inhibition of either kinin formation by kallikrein 28 ' 29 or activation of endogenous kininogenases, 30 the response to the administration of exogenous BK might be enhanced. Alternatively, augmentation of the renal vasodilator response to BK might have resulted from a direct effect of indomethacin, itself, unrelated to its effects on either endogenous prostaglandin synthesis or kinin formation. If the potentiation by indomethacin of the direct renal vascular action of BK were great enough, regardless of the mechanism, it is conceivable that a prostaglandin-mediated vasodilator component to BK might have been masked. The data presented here do not allow us to eliminate this possibility, although implicit in such a postulate is an unlikely large augmentation of the direct vasodilator response to BK following indomethacin administration if the contribution by prostaglandins to the vasodilator response to BK prior to indomethacin administration had been appreciable.
In conclusion, speculative considerations regarding the augmented renal vasodilator response to BK following indomethacin administration should not detract from the major findings of these experiments, namely, that BK infusion into the renal artery following administration of indomethacin is not associated with elimination or attenuation of the vasodilator response, in spite of the fact that "PGE 2 " efflux has been reduced virtually to zero. Therefore, these results are not compatible with the hypothesis that intrarenal prostaglandins mediate or amplify the renal vasodilator response to BK.
